Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary PCI

NCT03045562 is registered in ClinicalTrials.gov with Green Valley Group of China as lead sponsor.

NCT NCT03045562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03045562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute ST Segment Elevation Myocardial Infarction After Primary PCI
Lead sponsor
Green Valley Group of China
Phase
Phase 4
Overall status
Unknown status
Start date
January 20, 2017
Completion date
December 31, 2018
Enrollment
536 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stemi - st elevation myocardial infarction